Insulin–glucagon‐like peptide‐1 receptor agonist relay and glucagon‐like peptide‐1 receptor agonist first regimens in individuals with type 2 diabetes: A randomized, open‐label trial study

AIMS/INTRODUCTION: Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RA) might be less effective in patients with severe hyperglycemia, because hyperglycemia downregulated the GLP‐1 receptor in an animal study. To examine this hypothesis clinically, we compared the glucose‐lowering effects of GLP‐1 r...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeshita, Yumie, Kita, Yuki, Tanaka, Takeo, Goto, Hisanori, Nakano, Yujiro, Teramura, Chisato, Enyama, Yasufumi, Takamura, Toshinari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153847/
https://www.ncbi.nlm.nih.gov/pubmed/35034428
http://dx.doi.org/10.1111/jdi.13749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153847/
https://www.ncbi.nlm.nih.gov/pubmed/35034428
http://dx.doi.org/10.1111/jdi.13749

Ejemplares similares